In a study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with immune checkpoint inhibitors, a novel type of immunotherapy. The predictor was developed by Dr Noam Auslander, with other researchers in the Centre for Cancer Research (CCR) at the National Cancer … Continue reading Predictor indicates the potential success of melanoma treatment